Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer

Condition:   HER2-positive Breast Cancer Interventions:   Drug: Pyrotinib;   Drug: Trastuzumab Sponsor:   xuexin he Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials